A rare Amazonian cactus, the
Selenicereus wittii, is about to bloom for the first time in the UK at the Cambridge University Botanical Garden (CUBG). The rather unorthodox blooming experience of the moonlight cactus is currently being streamed on a webcam, and when it flowers – expected some time this weekend – it will show a rare glimpse into the 12-hour blooming period, which normally starts at sunset and is all over by sunrise.
“I’m so excited to see and share this most unusual flowering. It’s very rare to have this plant in our collection and we believe this is the first time the Moonflower has flowered in the UK,” said Alex Summers, Glasshouse Supervisor at the CUBG in a news release.
Ely Gold Royalties Inc.: Ely Gold Royalties Acquires Heavy Rare Earth El Campo Project, California
Vancouver, British Columbia (Newsfile Corp. - February 12, 2021) -
Ely Gold Royalties Inc.
Ely Gold or the
REO ) at its El Campo Project (
El Campo ) located in San Bernardino County, California. El Campo encompasses five contiguous unpatented mining claims that are surrounded by mining claims held by MP Materials
which make up the Mountain Pass Mine Property (
Mountain Pass ). Mountain Pass is the only operating rare earth mine in the Western Hemisphere.. El Campo is located along strike and 3.2 miles southeast of Mountain Pass
(see Figure #1). Ely Gold Acquired El Campo through staking.
AllStripes Announces Rare Disease Research Expansion into the United Kingdom
AllStripes approved to conduct research with patients residing in England, Scotland, Wales and Northern Ireland
AllStripes, a healthcare technology company dedicated to accelerating treatment research for patients with rare diseases, today announced it is expanding its rare disease research efforts into the United Kingdom. This is the company s first major expansion outside of North America AllStripes currently conducts research in the United States and Canada and represents a significant milestone for the rare disease community in the U.K. AllStripes seeks to utilize its cutting-edge technology to analyze community data to improve clinical trial design, and ultimately unlock new treatments that improve quality of life.